Spots Global Cancer Trial Database for Quality Of Life While Receiving Faslodex
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Quality Of Life While Receiving Faslodex
Official Title: Quality Of Life And Symptoms In Postmenopausal Women With Hormone Receptor Positive Disseminated Breast Cancer While Receiving Faslodex.
Study ID: NCT00643513
Conditions
Interventions
Study Description
Brief Summary: To study QoL related response, symptom spectrum and severity in disseminated breast cancer patients receiving Faslodex hormonal therapy.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Research Site, ?rasnodar, , Russian Federation
Research Site, Astrahan, , Russian Federation
Research Site, Blagoveshenk, , Russian Federation
Research Site, Chita, , Russian Federation
Research Site, Igevsk, , Russian Federation
Research Site, Kemerovo, , Russian Federation
Research Site, Kursk, , Russian Federation
Research Site, Magadan, , Russian Federation
Research Site, Moscow, , Russian Federation
Research Site, Obninsk, , Russian Federation
Research Site, Penza, , Russian Federation
Research Site, Petropavlovsk, , Russian Federation
Research Site, Rostov, , Russian Federation
Research Site, Salehard, , Russian Federation
Research Site, Samara, , Russian Federation
Research Site, Sankt-Petersburg, , Russian Federation
Research Site, Shahti, , Russian Federation
Research Site, Surgut, , Russian Federation
Research Site, Tiva, , Russian Federation
Research Site, Tomsk, , Russian Federation
Research Site, Tver, , Russian Federation
Research Site, Ufa, , Russian Federation
Research Site, Volgodonsk, , Russian Federation
Research Site, Yakutsk, , Russian Federation
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
